News

Filter

Current filters:

None

7960 to 7969 of 96672 results

Santen to co-promote Bayer and Regeneron's Eylea in Japan

09-05-2012

German drug major Bayer's (BAYN: DE) Japanese subsidiary, Bayer Yakuhin, and Santen Pharmaceutical (TYO:…

Asia-PacificBayerEyleaLicensingMarkets & MarketingOphthalmicsPharmaceuticalRegeneronSanten Pharmaceuticals

Spanish reforms and generics hit Almirall's 1st-qtr; Sativex progress

09-05-2012

Spain's leading drugmaker Almirall (ALM: MC) has reported a 5.9% decrease in sales for the first quarter…

AlmirallEuropeFinancialGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

Pozen out-licenses migraine drug candidate to Desitin for EU

09-05-2012

US drugmaker Pozen (Nasdaq: POZN) has entered into a license agreement with Germany's Desitin Arzneimittel…

Desitin ArzneimittelEuropeLicensingNeurologicalPharmaceuticalPozenSumatriptan and Naproxen Sodium Tablets

Dainippon Sumitomo's Latuda meets key endpoints in two Ph III trials in bipolar I depression

09-05-2012

Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) Co., Ltd. (DSP) announced has results from two…

Dainippon Sumitomo PharmaLatudaNeurologicalPharmaceuticalResearch

Intellect Neurosciences adds to its Alzheimer's development pipeline

08-05-2012

US biopharma firm Intellect Neurosciences (OTCBB: ILNS) has announced two new programs in its Alzheimer's…

BiotechnologyIntellect NeuroscienceLicensingNeurological

EU Commission clears 23 million-euro R&D aid to Novartis Italy for vaccines in developing countries

08-05-2012

The European Commission has concluded that 23 million euros ($30.2 million) public funding, which Italy…

FinancialNovartisPharmaceuticalResearchVaccines

Therapeutic monoclonal antibodies market - Is Biologics the answer to rising disease incidence?

08-05-2012

Existing adoption rates and commercial success of launched monoclonal antibodies (MAbs) for therapeutics…

BiotechnologyEuropeMarkets & Marketing

7960 to 7969 of 96672 results

Parexel

Parexel

Back to top